Research News

MenB vaccine programme cuts cases of meningitis and septicaemia in infants

BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4839 (Published 07 September 2016) Cite this as: BMJ 2016;354:i4839
  1. Jacqui Wise
  1. London

The number of cases of meningitis and septicaemia caused by meningococcal group B infection in infants has halved since the introduction of a new vaccine last year, Public Health England reports.1

All newborn babies in the United Kingdom are now routinely offered the vaccination against meningococcal group B, the world’s first infant programme to use this vaccine. In the 10 months since the programme began only 37 recorded cases of meningococcal B were recorded in infants aged under 1, compared with an average of 74 in the same …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe